351 related articles for article (PubMed ID: 31250135)
1. Acute Myeloid Leukemia: Update on Upfront Therapy in Elderly Patients.
Keiffer G; Palmisiano N
Curr Oncol Rep; 2019 Jun; 21(8):71. PubMed ID: 31250135
[TBL] [Abstract][Full Text] [Related]
2. Treating acute myeloid leukemia in older adults.
Wang ES
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):14-20. PubMed ID: 25696830
[TBL] [Abstract][Full Text] [Related]
3. Fitness in the elderly: how to make decisions regarding acute myeloid leukemia induction.
Rao AV
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):339-347. PubMed ID: 27913500
[TBL] [Abstract][Full Text] [Related]
4. The safety of treatment options for elderly people with acute myeloid leukemia.
Thomas X; Le Jeune C
Expert Opin Drug Saf; 2016 May; 15(5):635-45. PubMed ID: 26943698
[TBL] [Abstract][Full Text] [Related]
5. Management of Acute Myeloid Leukemia (AML) in Older Patients.
Abdallah M; Xie Z; Ready A; Manogna D; Mendler JH; Loh KP
Curr Oncol Rep; 2020 Jul; 22(10):103. PubMed ID: 32725515
[TBL] [Abstract][Full Text] [Related]
6. Precision medicine and novel molecular target therapies in acute myeloid leukemia: the background of hematologic malignancies (HM)-SCREEN-Japan 01.
Miyamoto K; Minami Y
Int J Clin Oncol; 2019 Aug; 24(8):893-898. PubMed ID: 31111287
[TBL] [Abstract][Full Text] [Related]
7. Profile of sapacitabine: potential for the treatment of newly diagnosed acute myeloid leukemia in elderly patients.
Lim MY; Jamieson K
Clin Interv Aging; 2014; 9():753-62. PubMed ID: 24851045
[TBL] [Abstract][Full Text] [Related]
8. Emerging pharmacotherapies for elderly acute myeloid leukemia patients.
Thomas X; Elhamri M; Heiblig M
Expert Rev Hematol; 2020 Jun; 13(6):619-643. PubMed ID: 32311298
[TBL] [Abstract][Full Text] [Related]
9. An extensive pharmacokinetic, metabolic and toxicological review of elderly patients under intensive chemotherapy for acute myeloid leukemia.
Kaur I; Constance JE; Kosak KM; Spigarelli MG; Sherwin CM
Expert Opin Drug Metab Toxicol; 2015 Jan; 11(1):53-65. PubMed ID: 25488904
[TBL] [Abstract][Full Text] [Related]
10. New drug approvals in acute myeloid leukemia: an unprecedented paradigm shift.
Kopmar NE; Estey EH
Clin Adv Hematol Oncol; 2019 Oct; 17(10):569-575. PubMed ID: 31730583
[TBL] [Abstract][Full Text] [Related]
11. Elderly patients with acute myeloid leukaemia: characteristics in biology, patients and treatment. Recommendations of the Working Group Geriatric Oncology of the German Society for Haematology and Oncology (DGHO), the Austrian Society for Haematology and Oncology (OGHO) and the German Society for Geriatrics (DGG).
Wedding U; Bokemeyer C; Meran JG; ; ;
Onkologie; 2004 Feb; 27(1):72-82. PubMed ID: 15007253
[TBL] [Abstract][Full Text] [Related]
12. Approach to the Older Patient with Acute Myeloid Leukemia.
Zimmer M; Kadia T
Curr Oncol Rep; 2023 Nov; 25(11):1203-1211. PubMed ID: 37688738
[TBL] [Abstract][Full Text] [Related]
13. Precision therapy for acute myeloid leukemia.
Yang X; Wang J
J Hematol Oncol; 2018 Jan; 11(1):3. PubMed ID: 29301553
[TBL] [Abstract][Full Text] [Related]
14. Alternative novel therapies for the treatment of elderly acute myeloid leukemia patients.
Isidori A; Venditti A; Maurillo L; Buccisano F; Loscocco F; Manduzio P; Sparaventi G; Amadori S; Visani G
Expert Rev Hematol; 2013 Dec; 6(6):767-84. PubMed ID: 24219553
[TBL] [Abstract][Full Text] [Related]
15. Emerging treatment strategies for acute myeloid leukemia (AML) in the elderly.
Kuendgen A; Germing U
Cancer Treat Rev; 2009 Apr; 35(2):97-120. PubMed ID: 18951721
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic decision-making in elderly patients with acute myeloid leukemia: conventional intensive chemotherapy versus hypomethylating agent therapy.
Oh SB; Park SW; Chung JS; Lee WS; Lee HS; Cho SH; Choi YS; Lim SN; Shin HJ;
Ann Hematol; 2017 Nov; 96(11):1801-1809. PubMed ID: 28828639
[TBL] [Abstract][Full Text] [Related]
17. Updates on DNA methylation modifiers in acute myeloid leukemia.
Contieri B; Duarte BKL; Lazarini M
Ann Hematol; 2020 Apr; 99(4):693-701. PubMed ID: 32025842
[TBL] [Abstract][Full Text] [Related]
18. Cutting Edge Molecular Therapy for Acute Myeloid Leukemia.
Miyamoto K; Minami Y
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698349
[TBL] [Abstract][Full Text] [Related]
19. Management of toxicities associated with targeted therapies for acute myeloid leukemia: when to push through and when to stop.
Wang ES; Baron J
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):57-66. PubMed ID: 33275692
[TBL] [Abstract][Full Text] [Related]
20. Advances in the treatment of elderly and frail patients with acute myeloid leukemia.
Amadori S; Del Principe MI; Venditti A
Curr Opin Oncol; 2014 Nov; 26(6):663-9. PubMed ID: 25162330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
